Live market screen
Commercial Space Company Risk / Opportunity Ranking
Opportunity/risk view across launch, satellites, SAR, earth observation, defense demand, financing events, and execution risk.
Updated June 27, 2026
Opportunity view
Showing rows 121-140 of 438; 20 rows per page.
| Rank | Company | Score | Thesis / Evidence |
|---|---|---|---|
| 121 | Azista Industries Private Limited lowweak | Opp 3 Risk 2 | Thesis: Reviewed evidence rationale says Azista Industries successfully imaged the ISS using its AFR satellite and notes potential uses in space situational awareness and missile monitoring. If current, successful imaging and dual-use application potential support a modest 1 year+ opportunity case. Why now: The only support cited is article in the membership rationale. Because the company coverage report shows zero articles after recent evidence window and zero evidence after recent evidence window, there is no robust timing catalyst beyond the historical demonstration narrative. Caveats: Single-article support only, and not available as active evidence. No direct evidence on customer conversion, regulatory adoption, or funding. Private-company visibility is limited in these reviewed sources. |
| 122 | Bellatrix Aerospace lowweak | Opp 3 Risk 2 | Thesis: Reviewed evidence membership rationale describes Bellatrix Aerospace as a space propulsion company partnering on a VLEO satellite mission using its air-breathing electric propulsion platform. If current, that points to differentiated technology and a potentially durable 1-year-plus opportunity setup, but the reviewed sources lack citeable direct evidence or article. Why now: Why now is only moderate in theory because propulsion/platform partnerships can matter over a 1-year-plus horizon, but these reviewed sources does not provide recency-anchored evidence after recent evidence window. Caveats: No direct evidence with available for citation. Technology differentiation is only inferred from membership rationale and is not independently corroborated in available evidence. |
| 123 | D-Orbit lowweak | Opp 3 Risk 2 | Thesis: D-Orbit appears strategically positioned in space logistics and in-orbit servicing, with reviewed sources rationale referencing an ESA award and supporting context noting prior Series D funding, but the retained in-window evidence is weak and mostly undated context. Why now: Why-now is weak because retained evidence after recent evidence window is mostly undated context; one cited article is from February 14, 2026 and therefore outside the 90-day evidence window, while the remaining available context is undated. Evidence
Caveats: Reviewed evidence membership rationale mentions a €119 million ESA contract, but no citeable retained row for that contract is included here. Series D funding mention is in a February 14, 2026 article outside the 90-day recent evidence window. Undated context is not recency proof. |
| 124 | Fujitsu lowweak | Opp 3 Risk 1 | Thesis: Fujitsu has a plausible long-horizon opportunity angle because the reviewed sources' membership rationale says it signed an MOU with BULL to develop a high-precision space situational awareness service for Japan. That suggests direct participation in an SDA-related service, but the reviewed sources still frames Fujitsu primarily as a large IT/services company and provides no direct positive evidence row or after recent evidence window (: and; not provided in reviewed sources). Why now: An MOU in SDA could matter over a 1 year+ horizon if it converts into deployments or service revenue, but the reviewed sources offers no direct dated evidence inside recent evidence window and no article to validate timing. Caveats: Large diversified company; reviewed sources does not show materiality of space effort. MOU is weaker than signed commercial contract revenue evidence. No direct article content or is available in reviewed sources. |
| 125 | GalaxySpace lowweak | Opp 3 Risk 2 | Thesis: GalaxySpace has some strategic optionality because the reviewed sources say it set up a space computing research institute and places it in space computing and satellite communications context, but that is early and not enough for a strong opportunity call. Why now: The reviewed sources references article: for the research institute setup, yet does not provide the article or direct event details to assess timing or commercial conversion. Caveats: Only one article is considered and no representative article object is provided. Research institute formation is weaker than product, contract, or financing milestones. Commercial impact timing is unclear. |
| 126 | Gate Space lowweak | Opp 3 Risk 2 | Thesis: Gate Space has a modest opportunity case because an undated supporting article context item says it won 6.3 million euros in funding from a government-backed accelerator program, which could support longer-horizon development if still current Why now: For a 1 year+ horizon, funding can matter, but recency is uncertain because the article is explicitly undated and the reviewed sources say undated external evidence is relevance context rather than recency proof Evidence
Caveats: The evidence is weak context and supporting article context, not direct structured company event/fact evidence. The article is undated; the reviewed sources explicitly says recency-sensitive claims should be treated cautiously. Same-article repeated rows are not independent confirmation. |
| 127 | Globalstar lowweak | Opp 3 Risk 4 | Thesis: Globalstar's cohort fit as a satellite communications and direct-to-device company is clear from the membership rationale, but these reviewed sources provide no in-window direct evidence to support a stronger opportunity ranking. Why now: There is effectively no why-now evidence in this row: the recent evidence review shows zero kept rows after the March 29, 2026 cutoff and no representative articles are provided. Caveats: The phase-2 rationale mentions Amazon acquisition-related articles, but those supporting articles are not included in the available evidence for this row. Scores remain low because absence of evidence is not positive evidence. |
| 128 | Goonhilly Earth Station Ltd lowweak | Opp 3 Risk 3 | Thesis: Among this screen, Goonhilly has the strongest stated strategic relevance because the reviewed sources' membership rationale says it has ground-station/COMSAT revenue and is involved in a transaction with Intuitive Machines, implying potentially durable space-infrastructure relevance over a 1 year+ horizon. However, the reviewed sources provide no retained direct evidence or article summaries to verify timing or terms, so the opportunity case remains weak. Why now: The only 'why now' available is the reviewed sources' statement that Goonhilly is being acquired by Intuitive Machines, cited in phase-2 support, and: but no, timestamps, or retained evidence are provided, so recency and sequence cannot be validated. Caveats: The reviewed sources rationale states Goonhilly has ground-station/COMSAT revenue and is being acquired by Intuitive Machines, tied to, and: but no or retained evidence are present. Coverage debug still shows articles after recent evidence window = 0 and evidence after recent evidence window = 0. Because chronology cannot be verified, transaction-state claims should be treated cautiously. |
| 129 | GS Yuasa Corporation lowweak | Opp 3 Risk 1 | Thesis: GS Yuasa has the cleanest stated product adjacency in the reviewed sources because the membership rationale says it is listed as a key player in a space battery market report. If that positioning reflects real participation in spacecraft power systems, it could matter over a 1 year+ horizon; however, the reviewed sources provide no retained direct evidence or dated summaries, so the opportunity score remains modest. Why now: There is no verified near-term catalyst, but the reviewed sources' phase-2 rationale references saying GS Yuasa was named as a key player in a space battery market report. Without, timing detail, or retained evidence, recency is uncertain. Caveats: The rationale cites, but no or retained article text is provided. Being listed as a key player in a market report is weaker than direct contract, launch, or financial evidence. No retained evidence remain after the 90-day recent evidence window. |
| 130 | HEO lowweak | Opp 3 Risk 2 | Thesis: Possible long-horizon opportunity from being listed as operating and from an undated mention of a seven-figure BlackSky space domain awareness expansion contract for automated non-Earth imaging missions, but this is only supporting article context and recency is uncertain. Why now: Why now is weak because both cited items are undated, so the reviewed sources does not establish a fresh catalyst within the current evidence window. The only support is that HEO appears in current reviewed sources context as an operating company and as associated with a contract mention, but recency cannot be confirmed from the reviewed sources Evidence
Caveats: Both supporting items are undated, so recency is uncertain. Support is supporting article context, not stronger company-specific dated event evidence. Same-article repeated rows in the reviewed sources are not independent confirmation. |
| 131 | Hula Earth lowweak | Opp 3 Risk 1 | Thesis: There is a weak, article-level opportunity case that Hula Earth is an early-stage biodiversity monitoring platform using satellite imagery and that it had raised seed funding by the time of the cited profile, which could support long-horizon company development. However, this is not direct event/fact evidence in the reviewed sources; it is external article context only. Why now: The only dated retained context is a Startup Intros profile with April 16, 2026, stating Hula Earth uses IoT sensors and satellite imagery and had raised €1.6 million in seed funding; that is recent enough for a 1 year+ watchlist but too weak for a high-conviction thesis. Evidence
Caveats: Evidence is weak context and supporting article context, not direct company event/facts. The funding itself is described as having occurred in November 2024 inside an April 16, 2026 profile, so exact recency of the financing event is older than the profile date. Reviewed evidence itself says Earth observation fit is plausible but not strong from these reviewed sources alone. |
| 132 | HyPrSpace lowweak | Opp 3 Risk 4 | Thesis: HyPrSpace has some long-horizon upside as a launch startup because the reviewed sources membership rationale says it raised a €21M Series A and is developing hybrid propulsion for a small launch vehicle and suborbital prototype. Why now: The reviewed sources does not provide recent evidence window-supported article details for the cited raise and development milestones, so the timing case is under-evidenced. Caveats: No representative articles or direct evidence are available after recent evidence filtering. The opportunity view rests only on the membership rationale rather than article-level evidence available for citation. |
| 133 | Institute for Q-shu Pioneers of Space, Inc (iQPS) lowweak | Opp 3 Risk 2 | Thesis: The reviewed sources say iQPS is a private Japanese Earth-imaging company whose QPS-SAR satellites are launched on Rocket Lab missions. That indicates a functioning path to deployment and a potentially scalable SAR imaging platform over a 1 year+ horizon. Why now: Why now is only modest because launch-linked deployment could matter over a long horizon, but there are no available article summaries or dated events to establish current momentum. Caveats: Membership rationale references article IDs and, but no or summaries are provided. No direct evidence survived or were available into these reviewed sources after recent evidence window. Do not use relation context as counterparty propagation evidence. |
| 134 | IonQ lowweak | Opp 3 Risk 3 | Thesis: IonQ has a possible strategic long-horizon opportunity if the reviewed sources' referenced Capella Space subsidiary linkage and SDA prototype agreement ultimately create material space exposure, but the reviewed sources does not allow straightforward propagation from subsidiary or relation context to IonQ itself without stronger direct evidence. Why now: Potential 'why now' would be the referenced space-subsidiary contract pathway, but recency and direct materiality to IonQ are not validated in available evidence for the 90-day recent evidence window. Caveats: Phase-2 rationale references and: but no or summaries are provided in the reviewed sources. Relations and counterparty propagation are not allowed by default. Coverage debug shows zero evidence after recent evidence window despite a large article universe. |
| 135 | ispace lowweak | Opp 3 Risk 4 | Thesis: The reviewed sources places ispace in private lunar mission context and notes 'ispace Hakuto-R,' which indicates continuing relevance in lunar mission execution if the program remains active. Why now: The membership support cites: and: The reviewed sources' wording around a second attempt makes mission outcome and execution durability relevant over a 1 year+ horizon, but timing confidence is reduced because no evidence survived into the available set. Caveats: Risk thesis is inferred from reviewed sources rationale mentioning a prior failure, not from available direct negative evidence. No direct evidence confirms current mission status, financing, or customer pipeline. Recency and sequencing of mission milestones cannot be validated from the empty evidence table. |
| 136 | Kepler Aerospace lowweak | Opp 3 Risk 3 | Thesis: Reviewed evidence context describes Kepler Aerospace as an Indian New Space startup operating a GSaaS network, integrating ground stations, and working on CubeSat platforms and satellite communications infrastructure. That breadth could support a 1 year+ infrastructure thesis, but there is no available in-window evidence of contracts, deployments, or financing progress. Why now: No current catalyst is established. Membership support references article ID: but the reviewed sources provide no and shows no evidence after recent evidence window. Caveats: No direct evidence available after recent evidence window for this company. Membership rationale references article ID: but the reviewed sources provide no or article summary. Context includes relation/fact counts in support statistics, but relations are context-only and cannot be propagated as operating proof. |
| 137 | Kepler Communications lowweak | Opp 3 Risk 2 | Thesis: The reviewed sources places Kepler Communications in space communications, HydRON network or optical communications context, and also notes it as an Nvidia space-AI customer. If accurate and current, those references could support a strategic network and onboard compute opportunity over 1 year+. Why now: The reviewed sources references, and: in membership support, suggesting recent strategic context, but no post-recent evidence window evidence are actually available for scoring. Caveats: Reviewed evidence itself says support is somewhat contextual. Context-only references are weaker than direct event/fact evidence. No available evidence confirms deployment, revenue, or funding milestones. |
| 138 | LiveEO lowweak | Opp 3 Risk 2 | Thesis: Reviewed evidence rationale says LiveEO secured ESA funding for the Twinspector satellite constellation for infrastructure monitoring, which could support a 1 year+ commercialization path, but there is no directly citable within the recent evidence window evidence in the reviewed sources. Why now: Why-now cannot be established because no evidence remain after recent evidence filtering. Caveats: Phase2 membership rationale references, but no summary or evidence are provided for citation. Coverage debug shows articles after recent evidence window = 0 and evidence after recent evidence window = 0. Low scores reflect missing usable evidence, not a bearish business judgment. |
| 139 | Mach Industries lowweak | Opp 3 Risk 2 | Thesis: Among this screen, Mach Industries has one of the stronger but still weakly grounded setups because the reviewed sources' membership rationale says it is a startup that raised $300 million and builds aerospace/defense systems including a 'Stratos satellite platform.' If accurate, that suggests longer-horizon capital availability and product ambition, but the reviewed sources provide no direct positive evidence row or after recent evidence window to validate scale, timing, or execution (: not provided in reviewed sources). Why now: For a 1 year+ horizon, a large raise and mention of a satellite platform could matter if recent, but the reviewed sources does not provide usable dated evidence within the 90-day recent evidence window and explicitly reports zero available evidence after recent evidence window. Caveats: No article provided in reviewed sources. No direct event/facts are available after recent evidence window despite the membership rationale referencing a raise. Primarily defense-tech framing may limit pure-play space thesis relevance. |
| 140 | Maxar Technologies Inc. lowweak | Opp 3 Risk 2 | Thesis: Maxar has some residual opportunity appeal because the membership rationale cites a specific $500 million NASA deal in a commercial satellite imaging market report, which would be material if current, but the reviewed sources includes no retained evidence row or recent article summary to validate status or timing now. Why now: No retained evidence is available within the reviewed sources despite the membership rationale referencing a prior NASA deal article. That makes the name a weak current candidate under local-evidence-only rules. Caveats: No retained article summary or dated event row is provided for the cited NASA deal. Cannot elevate conviction based only on membership rationale. |
Risk view
Showing rows 81-100 of 438; 20 rows per page.
| Rank | Company | Score | Thesis / Evidence |
|---|---|---|---|
| 81 | Interlune lowweak | Opp 5 Risk 3 | Thesis: The company also carries execution risk because the reviewed sources provide no further retained evidence on milestone completion, follow-on awards, commercialization timing, or technical results. A single contract supports relevance but does not prove scalable economics. Why now: The key 'why now' is the cited NASA contract in article: but the reviewed sources does not include the article summary or, so exact date and latest status are not visible here. Caveats: Opportunity case relies on membership rationale rather than included direct article evidence. A $6.9M contract is positive validation, but contract size alone may not be enough to de-risk a lunar-resource business. No negative evidence is provided, so risk mostly reflects execution uncertainty. |
| 82 | IonQ lowweak | Opp 3 Risk 3 | Thesis: Risk stems from thesis leakage: the reviewed sources frames IonQ primarily as parent/acquirer, while the strongest space-specific evidence appears to sit at subsidiary level, so investors could overstate IonQ's direct space-business impact based on insufficient company-specific proof. Why now: Potential 'why now' would be the referenced space-subsidiary contract pathway, but recency and direct materiality to IonQ are not validated in available evidence for the 90-day recent evidence window. Caveats: Phase-2 rationale references and: but no or summaries are provided in the reviewed sources. Relations and counterparty propagation are not allowed by default. Coverage debug shows zero evidence after recent evidence window despite a large article universe. |
| 83 | Iridium Communications Inc. lowmedium | Opp 5 Risk 3 | Thesis: Risk is moderate-low because there is no direct adverse evidence, but the reviewed sources lack recent company-specific contract, financing, or product milestone catalysts, so the case depends more on strategic position than on fresh business acceleration. Why now: The current support is an April 3, 2026 article-level overview of Iridium’s constellation and service footprint rather than a new event, so timing fit is only medium. Evidence
Caveats: Evidence is supporting article context, not a fresh contract or earnings-linked milestone. |
| 84 | Kepler mediummedium | Opp 6 Risk 3 | Thesis: Risk remains moderate because the evidence is primarily a company-source article and supporting article context rather than independent dated event evidence. The reviewed sources show no adverse developments, but also limited third-party confirmation. Why now: The latest visible evidence is dated June 23, 2026, making the milestone recent within the 90-day recent evidence window. The article explicitly frames this as the beginning of an operational network, which is more relevant to a 1 year+ horizon than a short-lived announcement. Evidence
Caveats: Primary evidence is from Kepler's own site. No direct contract, revenue, or financing detail is provided in the visible evidence. Same article appears in both representative and weak-context forms, which is not independent confirmation. |
| 85 | Kepler Aerospace lowweak | Opp 3 Risk 3 | Thesis: There is no direct negative evidence available. The main risk is that the business description is broad but unsupported by current, citable post-recent evidence window evidence, leaving commercialization and scale uncertain. Why now: No current catalyst is established. Membership support references article ID: but the reviewed sources provide no and shows no evidence after recent evidence window. Caveats: No direct evidence available after recent evidence window for this company. Membership rationale references article ID: but the reviewed sources provide no or article summary. Context includes relation/fact counts in support statistics, but relations are context-only and cannot be propagated as operating proof. |
| 86 | L3Harris Technologies mediummedium | Opp 6 Risk 3 | Thesis: Risk is lower than many peers in these reviewed sources because there is no cited direct adverse evidence, but the ranking is capped by limited fresh company-specific evidence within the 90-day window and reliance on supporting article context rather than detailed award economics attributable specifically to L3Harris. Why now: The recent timing anchor is the April 8, 2026 Andromeda article. Older 2020 MOSSAIC history exists in the reviewed sources but should not drive the current timing view because it is outside the recent evidence window and materially older than the current contract context. Evidence
Caveats: Current opportunity case depends on supporting article context rather than available direct positive events. The reviewed sources includes an older 2020 contract article, but that is not recent support for 'why now'. |
| 87 | Loft Orbital mediummedium | Opp 7 Risk 3 | Thesis: Risk exists because the positive case is largely supporting article context from external supporting source sources rather than direct dated events in the reviewed sources, and execution remains significant given a 10-satellite constellation deployment and launch timeline. But there is no retained material adverse evidence. Why now: Why now is credible for a 1 year+ horizon because several dated articles from 2026 establish a recent contract win and near-forward deployment timeline: Loft announced on April 30, 2026 a multi-year CNES contract worth up to tens of millions of euros with first satellite scheduled to launch in Q4 2026. Via Satellite on May 1, 2026 described a 10-satellite EO constellation under that contract. SpaceNews on May 5, 2026 said Loft is expanding into 'full-service constellation deals'. Evidence
Caveats: Most retained support is supporting article context, which the reviewed sources treats as bounded context and weaker than direct dated event/fact evidence. Several favorable funding articles for Loft are dated January 2025 and were dropped by the 90-day recent evidence window, so they should not drive the current score. Execution risk remains around deploying the constellation and meeting the stated 2026 launch timing. |
| 88 | MDA Space Ltd. lowweak | Opp 4 Risk 3 | Thesis: Risk is moderate because the available evidence is entirely undated external article context, making recency and state-of-business uncertain. Why now: Why-now is weak because both available representative articles are undated, so current timing and whether these items remain incremental versus already absorbed is uncertain Evidence
Caveats: Both cited articles are undated; recency is uncertain. Support is weak and based on article context, not direct positive events. No material adverse evidence is available, but no strong current catalyst is validated either. |
| 89 | Modul8 lowweak | Opp 4 Risk 3 | Thesis: Risk remains moderate because the reviewed sources supplies no available positive evidence after recent evidence window to confirm timing, contract status, or deployment progress; mission-heavy lunar communications programs can be timing-sensitive, but these reviewed sources gives no adverse proof either. Why now: Among sparse names, the stated combination of funding plus lunar communications program exposure could matter over 1 year+, but recency cannot be validated from served evidence. Caveats: The strongest claims are only in membership rationale and not backed by citeable -bearing evidence in the reviewed sources. No negative evidence does not equal low fundamental risk. |
| 90 | Muon Space lowweak | Opp 3 Risk 3 | Thesis: Risk is balanced with opportunity because the available evidence is mostly weak supporting article context rather than direct contract, financing, or milestone evidence, leaving business traction and near-medium term scaling uncertain. Why now: The most recent dated context is a May 22, 2026 job posting indicating contracting and legal operations needs, which may imply organizational buildout but is weak evidence for a major catalyst. Evidence
Caveats: The reviewed sources contain no direct positive or negative company-specific events. The May 22, 2026 job posting is operational context, not proof of revenue or contracts. Citation |
| 91 | NordSpace Corp. lowweak | Opp 3 Risk 3 | Thesis: No direct adverse evidence is available, but development-stage rocket businesses carry obvious execution dependency; in these reviewed sources that risk cannot be upgraded to high because the evidence does not show a specific setback, only insufficient current confirmation. Why now: The only directional clue is the membership-support article reference: but the reviewed sources includes no, no summary, and no available post-recent evidence window evidence, so timing and durability are uncertain. Caveats: No direct evidence available after recent evidence window for this company. Membership rationale references article ID: but the reviewed sources provide no or article summary. Opportunity case relies on generic funding support mention without current milestone evidence. |
| 92 | Northrop Grumman Corp mediumstrong | Opp 8 Risk 3 | Thesis: Risk is present but comparatively modest in the reviewed sources because no material adverse event is cited. The main risk is that the evidence is largely supporting article context and program participation, so exact economic contribution, timing, and competitive share are not fully established here. Why now: The setup is current and cumulative: April 8, 2026 Andromeda participation, June 1, 2026 Golden Dome interceptor partnership, and June 22, 2026 award of a $398M protected satcom contract all fall within the 90-day recent evidence window and point to sustained momentum. Evidence
Caveats: The reviewed sources does not provide direct business impact breakdowns beyond the $398M contract article. Some support is supporting article context rather than dated events. |
| 93 | NorthStar Earth & Space lowweak | Opp 4 Risk 3 | Thesis: Risk is moderate because evidence coverage is very thin, and the reviewed sources offers mainly context that the company planned to go public via SPAC, without stronger direct proof on operational milestones or contract conversion in this company row. Why now: The only dated evidence in this row is an April 27, 2026 article-level summary stating NorthStar Earth & Space plans to go public in a SPAC deal at a $300 million valuation. That may matter over a 1 year+ horizon, but the reviewed sources does not provide stronger company-specific direct evidence here. Evidence
Caveats: Coverage is extremely thin in this row: only one external article and no direct positive or negative dated events. The phase-2 rationale mentions a CAD$40M+ Royal Canadian Air Force contract, but that contract evidence is not directly surfaced in the available evidence fields for this output row, so it should not be elevated beyond the membership rationale. |
| 94 | Open Cosmos mediummedium | Opp 7 Risk 3 | Thesis: Risk is present but not strongly evidenced as negative news. The main risks are that the evidence is supporting article context rather than direct events, and one supporting item concerns spacecraft supply to a military mission rather than direct revenue or contract award to Open Cosmos. Why now: The timing is favorable for a 1 year+ horizon because the latest dated evidence on June 17, 2026 indicates market entry and operation of the first telecom satellites, which can matter over a multi-quarter rollout period. A prior April 8, 2026 article also shows Open Cosmos spacecraft being used in the Orpheus UK military mission, adding defense-adjacent relevance. These dates are source dates extracted from the article summaries. Evidence
Caveats: Evidence is external article context and weak-context rows, not direct positive events. Same-article repeated rows are not independent confirmation. |
| 95 | Orbital lowweak | Opp 4 Risk 3 | Thesis: Risk is also meaningful because the same article describes an early-stage startup with only a $5 million pre-seed raise pursuing an extremely ambitious plan involving an in-orbit demo next year and more than 100,000 orbital data centers, which raises execution and scale risk, although this is supporting article context rather than direct adverse evidence, June 10, 2026). Why now: The recency is relatively fresh: the is based on June 10, 2026, inside the 90-day recent evidence window, and it frames both new capital and a next-year demo as near-to-medium-term strategic milestones. Evidence
Caveats: All retained evidence is weak context supporting article context; there is no direct positive event/fact available. Same-article repeated rows are not independent confirmation. The opportunity case depends on an early-stage roadmap and financing announcement; commercial traction is not directly evidenced in retained rows. |
| 96 | Orbital Recovery Crew lowweak | Opp 3 Risk 3 | Thesis: Risk is also material because the evidence is limited to the company's own site and supporting article context, with no independent retained event evidence for contracts, missions, financing, customers, or regulatory outcomes; the same page also conditions service availability on manifest availability and continuing cooperation of regulatory bodies. Why now: The only retained evidence is a page with May 21, 2026, within the 90-day window, indicating recent discoverable claims of operations and service scope, but not a third-party validated catalyst. Evidence
Caveats: Evidence is company-site article context, not independent confirmation. No direct positive or negative dated events are available. Same-article repeated rows are not independent confirmation. |
| 97 | Overview Energy lowweak | Opp 4 Risk 3 | Thesis: The technology area appears highly ambitious and execution-sensitive, but no direct negative evidence is provided in the reviewed sources. Why now: The likely catalyst is the reported Air Force contract, yet the reviewed sources gives no retained article summary or evidence row to establish recency or contract scale. Caveats: Phase2 membership rationale references: but no article summary or evidence are available. Coverage debug shows articles after recent evidence window = 0 and evidence after recent evidence window = 0. |
| 98 | Pacific Defense lowweak | Opp 4 Risk 3 | Thesis: Despite the favorable context, the reviewed sources contain no post-recent evidence window evidence, no -backed article summary, and no fresh proof of follow-on contracts or operational success after the demo; that limits conviction and leaves execution risk unresolved. Why now: The company appears more advanced than several peers because the reviewed sources references an on-orbit demo under contract, but there is no citable recency signal beyond membership support article ID: and no available evidence after recent evidence window. Caveats: No direct evidence available after recent evidence window for this company. Membership rationale references article ID: but the reviewed sources provide no or article summary for citation. Opportunity score is relative within a weak-evidence batch, not high absolute conviction. |
| 99 | Payload Aerospace, S.A. lowweak | Opp 2 Risk 3 | Thesis: Main risk is evidence opacity and recency uncertainty rather than documented adverse events. The reviewed sources show one article considered but zero article IDs after recent evidence window and zero evidence available after recent evidence window, so business-state visibility is poor. Why now: Why now is weak because the reviewed sources' coverage debug shows zero article IDs after the March 29, 2026 cutoff and zero evidence after recent evidence window; any older fundraising context may no longer capture current business state. See support references listing article in the membership rationale, but no or article detail is provided in the reviewed sources, so recency and context cannot be independently assessed. Caveats: No -bearing article detail is provided for the fundraising support article, so factual claims beyond the membership rationale cannot be expanded. Coverage debug shows articles after recent evidence window = 0 and evidence after recent evidence window = 0, limiting confidence. |
| 100 | Planet Labs PBC lowweak | Opp 3 Risk 3 | Thesis: Risk is moderate because the reviewed sources lack recent direct evidence on contracts, growth, financing, or setbacks, leaving the current business trajectory uncertain. Why now: Why-now is weak: the only in-window evidence is an April 5, 2026 startup-listing article describing Planet as operating its own satellite constellation and geospatial analytics platform, which is durable context but not a clear catalyst. Evidence
Caveats: Evidence is only supporting article context, not direct company event or fact evidence with strong materiality. No direct positive or negative dated events are available. This is a low-conviction watchlist name in these reviewed sources. |